1-216073261-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BP4_Strong

The NM_206933.4(USH2A):​c.5612G>A​(p.Gly1871Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000266 in 1,613,784 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G1871G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )

Consequence

USH2A
NM_206933.4 missense

Scores

7
5
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:5B:3

Conservation

PhyloP100: 4.81

Publications

6 publications found
Variant links:
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
USH2A-AS2 (HGNC:40605): (USH2A antisense RNA 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 10 uncertain in NM_206933.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0653944).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USH2ANM_206933.4 linkc.5612G>A p.Gly1871Asp missense_variant Exon 28 of 72 ENST00000307340.8 NP_996816.3 O75445-1
USH2A-AS2NR_125992.1 linkn.136+661C>T intron_variant Intron 1 of 2
USH2A-AS2NR_125993.1 linkn.136+661C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USH2AENST00000307340.8 linkc.5612G>A p.Gly1871Asp missense_variant Exon 28 of 72 1 NM_206933.4 ENSP00000305941.3 O75445-1

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
156
AN:
152040
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000351
AC:
88
AN:
250594
AF XY:
0.000221
show subpopulations
Gnomad AFR exome
AF:
0.00320
Gnomad AMR exome
AF:
0.000348
Gnomad ASJ exome
AF:
0.000795
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.000492
GnomAD4 exome
AF:
0.000186
AC:
272
AN:
1461626
Hom.:
0
Cov.:
31
AF XY:
0.000175
AC XY:
127
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.00275
AC:
92
AN:
33474
American (AMR)
AF:
0.000470
AC:
21
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.00111
AC:
29
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53400
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000899
AC:
100
AN:
1111912
Other (OTH)
AF:
0.000364
AC:
22
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
157
AN:
152158
Hom.:
0
Cov.:
32
AF XY:
0.00102
AC XY:
76
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.00291
AC:
121
AN:
41514
American (AMR)
AF:
0.00124
AC:
19
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68002
Other (OTH)
AF:
0.00237
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
8
16
25
33
41
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000468
Hom.:
1
Bravo
AF:
0.00124
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000362
AC:
44
EpiCase
AF:
0.000273
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:5Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 13, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Observed with a second USH2A variant (phase unknown) in a patient with retinitis pigmentosa and in an unrelated patient with hearing loss in published literature (PMID: 30902645, 34837038); Observed in the heterozygous state with no other variant in the USH2A gene in a patient with retinitis pigmentosa in published literature; patient also harbored a variant in the EYS gene (PMID: 26806561); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34837038, 34426522, 32483926, 26806561, 30902645, 33623043) -

Aug 25, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1Benign:1
Oct 25, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Gly1871Asp in exon 28 of USH2A: This variant is not expected to have clinical significance because it has been identified in 0.3% (36/10338) of African chromo somes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs140895792). -

Jul 31, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: USH2A c.5612G>A (p.Gly1871Asp) results in a non-conservative amino acid change located in the Laminin G (IPR001791) and Fibronectin type III (IPR003961) domains of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00035 in 250594 control chromosomes (gnomAD). This frequency is not higher than expected for a pathogenic variant in USH2A causing Usher Syndrome (0.00035 vs 0.011), allowing no conclusion about variant significance. c.5612G>A has been reported in the literature in individuals affected with hearing loss and retinitis pigmentosa (examples: Perez-Carro_2015, Martin-Merida_2019, Adeyemo_2022). These reports do not provide unequivocal conclusions about association of the variant with Usher Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 34837038, 33623043, 30902645, 26806561). ClinVar contains an entry for this variant (Variation ID: 48537). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Retinitis pigmentosa 39 Pathogenic:1
Jun 23, 2021
DBGen Ocular Genomics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Childhood onset hearing loss Uncertain:1
Jul 08, 2021
National Institute on Deafness and Communication Disorders, National Institutes of Health
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

PP3 (non REVEL) / Modifications from PMID: 30311386 for classification: The genetic causes of hearing loss have not yet been well characterized in the Yoruba population, and the information regarding variant MAF in this population is still limited, so we did not exclude any variant based on their "high" MAF. PP3 criteria was applied even if the REVEL score was below 0.7, if at least two of the pathogenicity prediction algorithms used predicted that the variant was damaging or likely damaging. -

Usher syndrome type 2A Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.026
T
BayesDel_noAF
Pathogenic
0.19
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
T
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.70
T
M_CAP
Pathogenic
0.43
D
MetaRNN
Benign
0.065
T
MetaSVM
Uncertain
0.47
D
MutationAssessor
Pathogenic
3.0
M
PhyloP100
4.8
PrimateAI
Benign
0.43
T
PROVEAN
Uncertain
-3.6
D
REVEL
Pathogenic
0.66
Sift
Uncertain
0.010
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.76
MVP
0.94
MPC
0.26
ClinPred
0.091
T
GERP RS
5.9
Varity_R
0.49
gMVP
0.49
Mutation Taster
=3/97
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140895792; hg19: chr1-216246603; COSMIC: COSV100237314; API